314 related articles for article (PubMed ID: 34899704)
1. Pharmacological Activation of cGAS for Cancer Immunotherapy.
Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
Front Immunol; 2021; 12():753472. PubMed ID: 34899704
[TBL] [Abstract][Full Text] [Related]
2. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
[TBL] [Abstract][Full Text] [Related]
3. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
Zhou S; Cheng F; Zhang Y; Su T; Zhu G
Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
[TBL] [Abstract][Full Text] [Related]
4. Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.
Lai J; Fu Y; Tian S; Huang S; Luo X; Lin L; Zhang X; Wang H; Lin Z; Zhao H; Lin S; Zhao J; Xu S; Li D; Cai S; Dong L; Qian J; Liang J; Li Q; Zhang Y; Fan J; Balderas R; Chen Q
Mol Ther; 2021 May; 29(5):1758-1771. PubMed ID: 33571681
[TBL] [Abstract][Full Text] [Related]
5. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.
Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z
Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856
[TBL] [Abstract][Full Text] [Related]
7. Triggering of the cGAS-STING Pathway in Human Plasmacytoid Dendritic Cells Inhibits TLR9-Mediated IFN Production.
Deb P; Dai J; Singh S; Kalyoussef E; Fitzgerald-Bocarsly P
J Immunol; 2020 Jul; 205(1):223-236. PubMed ID: 32471881
[TBL] [Abstract][Full Text] [Related]
8. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer.
Yan X; Yao C; Fang C; Han M; Gong C; Hu D; Shen W; Wang L; Li S; Zhu S
Int J Biol Sci; 2022; 18(2):585-598. PubMed ID: 35002511
[No Abstract] [Full Text] [Related]
9. Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy.
Yang L; Wang Y; Song Y; Li Z; Lei L; Li H; He B; Cao J; Gao H
J Control Release; 2024 Jun; 370():354-366. PubMed ID: 38685387
[TBL] [Abstract][Full Text] [Related]
10. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
11. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.
Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade.
Wang M; Huang Y; Chen M; Wang W; Wu F; Zhong T; Chen X; Wang F; Li Y; Yu J; Wu M; Chen D
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37620043
[TBL] [Abstract][Full Text] [Related]
14. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
[TBL] [Abstract][Full Text] [Related]
15. cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer.
Dan Q; Yang Y; Ge H
Curr Cancer Drug Targets; 2023; 23(5):354-362. PubMed ID: 36380440
[TBL] [Abstract][Full Text] [Related]
16. A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy.
Chen Y; Li R; Duan Q; Wu L; Li X; Luo A; Zhang Y; Zhao N; Cui K; Wu W; Liu T; Wan JB; Deng L; Li G; Hou L; Tan W; Xiao Z
Adv Sci (Weinh); 2024 Jun; ():e2400149. PubMed ID: 38898748
[TBL] [Abstract][Full Text] [Related]
17. cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and Development.
Ng KW; Marshall EA; Bell JC; Lam WL
Trends Immunol; 2018 Jan; 39(1):44-54. PubMed ID: 28830732
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.
Storozynsky Q; Hitt MM
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238631
[TBL] [Abstract][Full Text] [Related]
19. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
[TBL] [Abstract][Full Text] [Related]
20. Combination of STING agonist with anti-vascular RGD-(KLAKLAK)
Czapla J; Drzyzga A; Ciepła J; Matuszczak S; Jarosz-Biej M; Pilny E; Cichoń T; Smolarczyk R
Cancer Immunol Immunother; 2024 Jun; 73(8):148. PubMed ID: 38832958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
